1[1]Ganesh V,Leonard G,Gomellam.Utilizati of Polymerase Chain reaction technology.Cancer,1998,82:1419-1442
2[2]Gribben J,Nadler L,Catolom,et al.Cytokeration 20 in human carcinomas.Cancer Treat Res,1995,76:249-255
3[3]Uehara H,Hany MA,Juhl H.The detection of disseminated tumor cells in bone marrow from colorectal cancer patients by a cytokeration-20 specific nested reverse transcriptase polymerase chain reaction is related the stage of disease.Diagn Mol Pathol,1995,12:2102-2120
5[5]Pao CC,Hor J,Rao B,et al.Sensitivity of specifity of reverse transcriptase polymerase chain reaction assays:the real challenge for molecular staging of prostatic carcinomars.J Clin Oncol,1997,15:1008-10022
6[6]Takeda S,Shibata,TuMb E,et al.Dectetion of illegitimate transcripts of prostate specific antigen mRNA in body by reverse transcriptions of polymerase chain reaction.Cancer,1992,70:2255-2263
7[7]Mireno JG,OHara M,Sylvain SM,et al.Detection of intraoperative tumor cell dissemination in patient with breast cancer by use of reverse transcription and polymerase chain reaction.Urology,1997,49:515-520
8[8]Cama CL,Olsson CA,Yu H,et al.Prostate specific antigen immunoreactivity in the milk of lactating women.J Urol,1996,155;553A-558
9[9]Smith B,Selby P,Wolfgang H,et al.Tumor malignancy defined by aberrant glycosylation and sphingolipid metabolism.Lancet,1991,338:1227-1231
10[10] Kunter U,Buer J,Berry Y.The prognosis value of the monoclonal antihodies HMFG in breast cancer.J Natl Cancer Inst,1996,88:590-597
